ENTO
NASDAQ
Entero Therapeutics Inc. - Common Stock
Healthcare
· Biotechnology
$2.85
-0.16 (-5.3%)
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$10.1M
ROE
-28.5%
D/E
1.26
Beta
1.21
52W
$1–$6
Price Chart
Fundamentals Trend
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -39.0% | -28.5% | -30.3% | -28.5% | -28.5% | -28.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 1.24 | 1.26 | 1.24 | 1.26 | 1.26 | 1.26 |
| Current Ratio | 2.90 | 2.81 | 2.90 | 2.81 | 2.81 | 2.81 |
Key Ratios
ROA (TTM)
-20.0%
P/B
0.1
EPS (TTM)
$-10.89
52W High
$5.84
52W Low
$0.97
$0.97
52-Week Range
$5.84
How does ENTO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ENTO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.1
▼
98%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ENTO profitability vs Biotechnology peers
ROE
-28.5%
▲
58%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-20.0%
▲
57%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
ENTO financial health vs Biotechnology peers
D/E ratio
1.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
2.8
▼
37%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲
25%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ENTO fundamentals radar
ENTO
Peer median
Industry
ENTO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ENTO vs peers: key metrics
Latest News
Nike Takes 'Intentional' Hit To Clear 'Unhealthy Inventory' In Q3 As CEO …
Yahoo Finance · Apr 04
WTI Dips After Big Crude Inventory Build, US Production Slows
ZeroHedge · Apr 01
Citi Raises its Price Target on Rentokil Initial plc (RTO) to 575 …
Yahoo Finance · Mar 25
How Zillow Preview affects Chicago’s battle over pre-market inventory
Yahoo Finance · Mar 25
Jim Cramer Highlights TJX Companies Are “Making a Killing By Scooping Up …
Yahoo Finance · Mar 25